Even scientists understand that the war on drugs never worked
A series of speakers were presented by a federal agency last week, dedicated specifically to recapitulating the science on the therapeutic potential of psilocybin mushrooms. The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is in charge of these events, where they discuss the most relevant topics on the subject. The speakers who participated wasted no time expressing their opinion of the war on drugs, rightfully pointing out that it never was successful.
It has said that even though psychedelics are classified as a Schedule I substance with no medical value in the eyes of federal law, clinical trials “are investigating psilocybin for treating cancer-related depression, for example, and also for its potential medicinal application in the treatment of a variety of serious psychiatric disorders.”
That is why the agency has now taken on the task of organizing a series of psilocybin research speakers and will take place over the next few weeks. The first event was held last Thursday, featuring professors from UCLA as well as Johns Hopkins University. The presentations focused on the use of psilocybin and various other aspects. Dr. Charles Grob of UCLA emphasized the need for greater diversity among participants in psychedelic studies while pointing out the tedious issue of funding. “I will say that the National Institutes of Health really hasn’t funded this area. As far as I know, since the late 1960s, they funded mechanistic questions but not actual treatment: whether psychedelics can have any role as a treatment model I think needs to be revisited,” he added.
The next event is expected to be held on May 27, where scientific perspectives on the advancement of public health initiatives will be discussed.